Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
2.
J Clin Microbiol ; 60(1): e0141021, 2022 01 19.
Artigo em Inglês | MEDLINE | ID: mdl-34613800

RESUMO

The performance of the Liofilchem omadacycline MIC Test Strip (MTS) was evaluated in a multisite study. Three testing sites collected/tested clinical isolates and one site tested challenge isolates that totaled 175 S. aureus, 70 S. lugdunensis, 121 E. faecalis, 100 E. faecium, 578 Enterobacterales, 142 Haemophilus spp., 181 S. pneumoniae, 45 S. anginosus group, 35 S. pyogenes,and 20 S. agalactiae. MIC testing was performed by CLSI broth microdilution (BMD) and MTS. Fastidious isolates testing included BMD and MTS testing with both CLSI and EUCAST Mueller-Hinton Fastidious (MH-F). In addition, each site performed reproducibility for nonfastidious and fastidious isolates and QC by MTS and BMD. All BMD and MTS results for the QC strains were within expected ranges, with exception of one MTS HTM result for H. influenzae ATCC 49247. Among reproducibility isolates, omadacycline MTS results were within one dilution of the modal MIC for 95.2% of nonfastidious Gram-positive, 100% of Gram-negative, 99.3% and 98.5% of fastidious isolates tested on CLSI and EUCAST media, respectively. MTS results for all study isolates were within one doubling dilution of the CLSI BMD MIC for 98.9% of S. aureus, 100% of S. lugdunensis, 98.3% of E. faecalis, 100% of E. faecium, and 99.6% of Enterobacterales. Essential agreement rates for CLSI and EUCAST MH-F agar compared to CLSI BMD were 98.2% and 98.2%, for H. influenzae, 91.1% and 73.6%, for S. pneumoniae and 100% and 85-91.7% for other streptococcus species, respectively. Based on CLSI media, all categorical errors were minor errors and categorical agreement rates were >90% with exception of C. freundii, S. lugdunensis, E. faecalis, S. anginosus and S. constellatus.


Assuntos
Antibacterianos , Staphylococcus aureus , Antibacterianos/farmacologia , Bactérias , Bactérias Gram-Negativas , Humanos , Testes de Sensibilidade Microbiana , Reprodutibilidade dos Testes , Tetraciclinas
3.
Eur J Clin Microbiol Infect Dis ; 32(7): 955-9, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23397233

RESUMO

Time-to-positivity (TTP) is defined as the length of time from the beginning of culture incubation to the detection of bacterial growth by an automated system. The objective of this study was to assess the clinical and microbiological implications of TTP among patients with Gram-negative bacilli (GNB) bacteremia. This was a prospective, single-center, observational study. Patients aged 18 years or older with one or more blood cultures growing GNB were included and followed until hospital discharge or death. Patients were excluded if they were without symptoms of infection, if they had polymicrobial culture, or if the culture was positive with an obligate anaerobe. A multivariate logistic regression analysis was performed to determine the predictors of in-hospital mortality, including TTP (primary endpoint), demographics, disease severity, comorbidities, pathogen type, source of infection, time to symptom resolution, hospital/intensive care unit (ICU) length of stay, adequacy of empiric antibiotics, and presence of an extended-spectrum beta-lactamase (ESBL)-producing bacteria. One hundred consecutive patients with GNB bacteremia were enrolled. TTP was an independent predictor of mortality; for every hour that TTP was shorter, the risk of mortality increased by 10% [odds ratio (OR) 1.10, 95% confidence interval (CI) 1.00-1.21, p = 0.049]. Other predictors of mortality included severity of illness, ESBL-producing GNB, and ICU admission within 24 h before culture. Mortality was highest among patients with inadequate empiric therapy (56% vs. 14%, p < 0.001) and TTP <11 h (23.1% vs. 8.3%, p = 0.18). Lactose-fermenting GNB had a shorter mean TTP than non-lactose fermenters (11.4 vs. 17.9 h, p = 0.001). Among patients with bacteremia due to GNB, TTP values are inversely associated with mortality risk.


Assuntos
Bacteriemia/diagnóstico , Técnicas Bacteriológicas/métodos , Bactérias Gram-Negativas/isolamento & purificação , Infecções por Bactérias Gram-Negativas/diagnóstico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/uso terapêutico , Bacteriemia/tratamento farmacológico , Bacteriemia/microbiologia , Feminino , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/microbiologia , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Análise de Sobrevida , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
4.
Zoonoses Public Health ; 59(4): 246-50, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22212633

RESUMO

Bordetella bronchiseptica is a zoonotic respiratory pathogen commonly found in domesticated farm and companion animals, including dogs and cats. Here, we report isolation of B. bronchiseptica from a sputum sample of a cystic fibrosis patient recently exposed to a kitten with an acute respiratory illness. Genetic characterization of the isolate and comparison with other isolates of human or feline origin strongly suggest that the kitten was the source of infection.


Assuntos
Infecções por Bordetella/complicações , Infecções por Bordetella/veterinária , Bordetella bronchiseptica/isolamento & purificação , Doenças do Gato/microbiologia , Fibrose Cística/complicações , Infecções Oportunistas/complicações , Infecções Respiratórias/veterinária , Zoonoses/microbiologia , Animais , Southern Blotting , Infecções por Bordetella/diagnóstico , Infecções por Bordetella/transmissão , Bordetella bronchiseptica/genética , Doenças do Gato/transmissão , Gatos , Criança , Fibrose Cística/microbiologia , Feminino , Humanos , Infecções Oportunistas/microbiologia , Polimorfismo de Fragmento de Restrição , Infecções Respiratórias/diagnóstico , Infecções Respiratórias/transmissão , Ribotipagem , Escarro/microbiologia
5.
Am J Manag Care ; 7(6 Suppl): S170-7, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11424585

RESUMO

Infectious disease experts and public health officials continue to warn the medical community and the public that more strains of respiratory tract pathogens are becoming resistant to the antibiotics commonly used to eradicate them. The inappropriate use of antibiotics to treat viral infections has contributed to the development of multidrug resistance in the 3 key bacterial pathogens that cause respiratory tract infections: Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Traditionally, susceptibility of pathogens to antibiotics has been evaluated with in vitro testing by minimum inhibitory concentration (MIC) determination, which has also been used to establish breakpoints between susceptible and resistant organisms based on MIC distributions. However, a more clinical approach has been developed based on the correlation of pharmacokinetics (PK) and pharmacodynamics (PD) of antimicrobials with MICs and clinical studies, thereby establishing the new concept of PK/PD breakpoints. New guidelines for outpatient management of respiratory tract infections have been based on PD parameters.


Assuntos
Resistência Microbiana a Medicamentos , Infecções Respiratórias/tratamento farmacológico , Infecções Respiratórias/microbiologia , Haemophilus influenzae/efeitos dos fármacos , Haemophilus influenzae/isolamento & purificação , Humanos , Testes de Sensibilidade Microbiana , Moraxella catarrhalis/efeitos dos fármacos , Moraxella catarrhalis/isolamento & purificação , Streptococcus pneumoniae/efeitos dos fármacos , Streptococcus pneumoniae/isolamento & purificação , Estados Unidos
6.
Antimicrob Agents Chemother ; 45(1): 339-41, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11120993

RESUMO

Thirty-two macrolide-resistant Streptococcus pyogenes isolates were found among 594 clinical isolates collected from 1990 to 1998 in Santiago, Chile, for an overall prevalence of 7.2%. Among the 32 resistant isolates, 28 (87.5%) presented the M phenotype and 4 (12. 5%) presented the MLS(B) phenotype. Serotyping and pulsed-field gel electrophoresis analysis showed genetic diversity among the resistant isolates.


Assuntos
Antibacterianos/farmacologia , Infecções Estreptocócicas/epidemiologia , Infecções Estreptocócicas/microbiologia , Streptococcus pyogenes/efeitos dos fármacos , Chile/epidemiologia , Clindamicina/farmacologia , Resistência Microbiana a Medicamentos , Eletroforese em Gel de Campo Pulsado , Eritromicina/farmacologia , Testes de Sensibilidade Microbiana , Fenótipo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Streptococcus pyogenes/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA